Skip to content

Insider · CIK 0001127430

Christine A Pellizzari

director

Files at IMNN (Imunon, Inc.), TPST (Tempest Therapeutics, Inc.). First filing -, latest -.

In brief

Christine A Pellizzari files SEC Form 4 as director at IMNN (Imunon, Inc.), and also at TPST (Tempest Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Christine A Pellizzari has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 31, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+6,934$1.59$11k15,076Aug 4, 2026
May 22, 2026IMNN
Imunon, Inc.
AGrant or award
Common Stock
+5,557$2.20$12k8,142May 27, 2026
Jan 27, 2026TPST
Tempest Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+1,230$0.00$01,230Jan 28, 2026
Jan 2, 2026IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+4,827$0.00$04,827Jan 6, 2026
Aug 4, 2025IMNN
Imunon, Inc.
AGrant or award
Common Stock
+2,248$9.20$21k2,248Aug 6, 2025
Aug 4, 2025IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+250$0.00$0250Aug 6, 2025
Mar 14, 2025IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+3,750$0.00$03,750Mar 18, 2025
Mar 15, 2024IMNN
Imunon, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+4,500$0.00$014,166Mar 18, 2024

Questions about Christine A Pellizzari

Answered from the filings on this page, as of the latest one.

Is Christine A Pellizzari buying or selling?

Christine A Pellizzari has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Christine A Pellizzari's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine A Pellizzari has 0.

Where does Christine A Pellizzari file Form 4?

Christine A Pellizzari has filed Form 4 at IMNN (Imunon, Inc.); TPST (Tempest Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.